Table 3.
Fat distribution measurements and serum levels of study cohort
| Total, n = 39 Median (SD) | EEC, n = 25 Median (SD) | NEEC, n = 14 Median (SD) | |
|---|---|---|---|
| Fat distribution | |||
| BMI (kg/m2) | 26.9 (7.9) | 27.5 (9.0) | 26.1 (4.7) |
| WC (cm) | 95.3 (15.8) | 97.8 (17.9) | 93 (11.0) |
| TAV (cm3) | 7529 (4633) | 7487 (5161) | 7570 (3484) |
| VAV (cm3) | 2772 (1677) | 2861 (1741) | 2668 (1610) |
| SAV (cm3) | 4544 (3230) | 4556 (3669) | 4544 (2181) |
| VAV% (%) | 33.4 (8.2) | 32.5 (8.3) | 34.4 (8.2) |
| Sex steroids | |||
| Estradiol (pmol/L) | 54 (38.4) | 49 (43.8) | 56 (27.2) |
| Androstenedione (nmol/L) | 1.8 (1.1) | 1.8 (1.1) | 1.7 (1.2) |
| Testosterone (nmol/L) | 0.7 (0.6) | 0.7 (0.6) | 0.6 (0.4) |
| DHEAS (μmol/L) | 2.4 (1.5) | 2.4 (1.3) | 2.31 (1.8) |
| Lipids | |||
| Cholesterol (mmol/L) | 5.1 (1.4) | 5.8 (1.3)* | 3.8 (1.4)* |
| HDL (mmol/L) | 0.8 (0.4) | 0.8 (0.4) | 0.6 (0.4) |
| LDL (mmol/L) | 3.5 (1.2) | 3.8 (1.1)* | 2.6 (1.2)* |
| NHDL (mmol/L) | 4.3 (1.3) | 4.5 (1.3)* | 3.2 (1.3)* |
| Triglycerides (mmol/L) | 1.5 (0.6) | 1.5 (0.6) | 1.5 (0.4) |
| Chol/HDL ratio | 7 (3.4) | 7 (3.3) | 8 (3.5) |
*significant differences at p < 0.05